Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
Guttman-Yassky E, Renert-Yuval Y, Bares J, Chima M, Hawkes JE, Gilleaudeau P, Sullivan-Whalen M, Singer GK, Garcet S, Pavel AB, Lebwohl MG, Krueger JG. Guttman-Yassky E, et al. Among authors: bares j. Allergy. 2022 Mar;77(3):897-906. doi: 10.1111/all.15071. Epub 2021 Sep 6. Allergy. 2022. PMID: 34460948 Free PMC article. Clinical Trial.
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI.
Kim HJ, Del Duca E, Pavel AB, Singer GK, Abittan BJ, Chima MA, Kimmel G, Bares J, Baum D, Gagliotti M, Genece J, Chu J, Lebwohl MG, Guttman-Yassky E. Kim HJ, et al. Among authors: bares j. Arch Dermatol Res. 2023 Mar;315(2):215-221. doi: 10.1007/s00403-022-02343-1. Epub 2022 Mar 13. Arch Dermatol Res. 2023. PMID: 35279741 Clinical Trial.
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot study.
Kim HJ, Singer GK, Del Duca E, Abittan BJ, Chima MA, Kimmel G, Bares J, Gagliotti M, Genece J, Chu J, Wilding G, Pavel AB, Guttman-Yassky E, Lebwohl MG. Kim HJ, et al. Among authors: bares j. J Am Acad Dermatol. 2021 Dec;85(6):1657-1660. doi: 10.1016/j.jaad.2020.12.073. Epub 2021 Jan 10. J Am Acad Dermatol. 2021. PMID: 33440217 Clinical Trial. No abstract available.
Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial.
Hashim PW, Chima M, Kim HJ, Bares J, Yao CJ, Singer G, Chen T, Genece J, Baum D, Kimmel GW, Nia JK, Gagliotti M, Lebwohl MG. Hashim PW, et al. Among authors: bares j. J Am Acad Dermatol. 2020 Feb;82(2):360-365. doi: 10.1016/j.jaad.2019.06.1288. Epub 2019 Jul 3. J Am Acad Dermatol. 2020. PMID: 31279028 Clinical Trial.
54 results